Drug and Medication Industry Market Research Reports in France, May 2013

France: Country Outlook, 2011, focus on Drug and Medication

• Country report
• March 2011
• 34 pages

... Heterogeneity, with an application to illicit drug markets. A consequence of these informational difficulties is that for a given level of quality, price dispersion is expected to be larger in illicit drugs ...

• Industries: Drug and Medication
• Countries: France

Brazil and Europe: Brief Overview, 2011, focus on Drug and Medication

• Country report
• October 2011
• 2 pages

... Injection, enabling perfect treatment compliance, and very swift action. The new anti-infective complies with the latest health authority requirements concerning the correct use of antibiotics as well ...

• Industries: Drug and Medication
• Countries: Brazil, France, Europe

France: Country Outlook, 2011, focus on Drug and Medication

• Country report
• February 2011
• 29 pages
• by Research Paper

... Have questioned how benfluorex was kept on the market despite it produced the same dangerous metabolite as an ingredient in anti-obesity drugs that were withdrawn from the market in 1997 for causing ...

• Industries: Drug and Medication
• Countries: France

Company Report: Drug and Medication in France and The United States for Year 2012

• Company report
• July 2012
• 2 pages

... And development, future clinical data and analysis, including post marketing, s by regulatory authorities, such as the fda or the ema, regarding whether and when to approve any drug, device or biological ...

• Industries: Drug and Medication
• Countries: France, United States

Company Report: Drug and Medication in The United States and Europe for Year 2012

• Company report
• January 2012
• 2 pages

... The world, represents groundbreaking and life-saving advances in medicine. As a sanofi company, genzyme benefits from the reach and resources of one of the world S largest pharmaceutical companies ...

• Industries: Drug and Medication
• Countries: United States, France, Europe

Company Report: Drug and Medication in The United States and France for Year 2012

• Company report
• September 2012
• 9 pages
• by Corporation

• Industries: Drug and Medication
• Countries: United States, France

Investor presentation: Drug and Medication in France for Year 2011

• Company report
• March 2011
• 38 pages

... In full. Finally, in those countries in which public or private health cover is provided, the impact of the financial crisis could cause medical insurance agencies to place added pressure on drug prices ...

• Industries: Drug and Medication
• Countries: France

Investor presentation: Drug and Medication in France for Year 2011

• Company report
• March 2011
• 38 pages

... In full. Finally, in those countries in which public or private health cover is provided, the impact of the financial crisis could cause medical insurance agencies to place added pressure on drug prices ...

• Industries: Drug and Medication
• Countries: France

Company Report: Drug and Medication in France for Year 2012

• Company report
• September 2012
• 2 pages

... Needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health ...

• Industries: Drug and Medication
• Countries: France

Company Report: Vaccine in The United States and Europe for Year 2011

• Company report
• March 2011
• 2 pages
• by Corporation

... Stage clinical development. Unchanged outlook for 2012 for the 2012 financial year, alk expects growth in vaccines sales of 3-5% and total revenue of up to dkk 2.4 Billion. Despite a record-high activity level ...

• Industries: Drug and Medication
• Countries: France, United States, Europe

Drug and Medication Market in France

• Industry report
• March 2011
• 22 pages

... Complete ongoing clinical trials: clonidine lauriad Amep doxorubicin transdrug : new clinical development plan presented to regulatory agencies corporate presentation shareholders value drivers 20 ...

• Industries: Drug and Medication
• Countries: France

Drug and Medication Industry in France and Japan

• Industry report
• January 2011
• 50 pages

... Imidazotetrazines (alkylating anticancer drugs) aminotriazines (alkylating anticancer drugs) steroids catecholamines (a-adrenergic agonists) dimethoxyquinazolines(a1-adrenergic blockers ...

• Industries: Drug and Medication
• Countries: France, World, Japan

Drug and Medication Sector in France

• Industry report
• January 2011
• 10 pages

• Industries: Drug and Medication
• Countries: World, France

Anti-inflammatory Business in Ukraine, France and Sweden

• Industry report
• September 2010
• 34 pages

... With the combination of grab and passive sampling techniques Presence of trace metals and some of pharmaceuticals (diclofenac, carbamazepine and ibuprofen) was at the dangerous level for the human health ...

• Industries: Drug and Medication
• Countries: Ukraine, France, Sweden

The French Opioid and Drug Sectors Brief

• Industry report
• June 2010
• 13 pages

... Controlling for the impact of non-random assignment to buprenorphine and methadone using heckman approach (first step model Probit model) xrhombus evaluating the impact of methadone and buprenorphine ...

• Industries: Drug and Medication
• Countries: France

Drug and Medication in Russian Federation and France : Innovation and Technology Trends

• Industry report
• November 2010
• 23 pages

... And glimeperide Significant player in amlodipine Profit enhancement measures to yield greater results jpy mnjpy mn south africa Growth sustained at over 32% in zar terms Sixth largest generic company ...

• Industries: Drug and Medication
• Countries: World, Russian Federation, France

Drug and Medication Market in France

• Industry report
• January 2011
• 10 pages

... In dermatology, well placed for vaccines, equine wormers, and electronic identification, virbac also occupies extremely competitive positions in new or high-potential markets such as dental care, geriatrics ...

• Industries: Drug and Medication
• Countries: World, France

Drug and Medication Business in The United Kingdom, France and Germany

• Industry report
• January 2011
• 6 pages

... Of clavulanic acid is excreted in the urine. The remainder is excreted as inactive metabolites. After repeated oral administration of the recommended dose in dogs and cats, there is no accumulation ...

• Industries: Drug and Medication
• Countries: United Kingdom, France, Germany

Drug and Medication Sector in France and Japan

• Industry report
• January 2011
• 50 pages

• Industries: Drug and Medication
• Countries: France, World, Japan

Antibiotic Sector Analysis in Argentina and France

• Industry report
• November 2011
• 71 pages

... Too Drugs has influence on antibiotic consumption; 27 generics for antibiotics (quinolones) : conclusions more generics/ Me too Decrease relative price increase antibiotic consumption (not true for all ...

• Industries: Drug and Medication
• Countries: Argentina, France

Vaccine Market in The United States and France

• Industry report
• September 2012
• 33 pages

... Usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. *Cdc general ...

• Industries: Drug and Medication
• Countries: United States, France

The French Antibiotic Industry Analysis

• Industry report
• October 2012
• 104 pages

... Data on the intestinal microflora as well as the results of the bioassays for antibiotic concentrations in faecal samples, telavancin has a favourable ecological profile. Antimicrobial resistance ...

• Industries: Drug and Medication
• Countries: France

Drug and Medication Production and Trade Statistics in The United States and France

• Industry report
• December 2012
• 25 pages

... Of generic 21 vancomycin (van) products approved for use in humans, based on experiments in a 22 neutropenic mouse thigh infection model. However, other animal models may be more 23 appropriate to decipher ...

• Industries: Drug and Medication
• Countries: United States, France

Drug Sector in France

• Industry report
• March 2013
• 44 pages

... Are seen first and foremost as businesses, in other words, as players seeking to make a profit: 90% (-1) Of the french and 96% of doctors believe that the aim of drug companies is to make a profit ...

• Industries: Drug and Medication
• Countries: France

The French Drug and Medication Industry

• Industry report
• May 2012
• 38 pages

• Industries: Drug and Medication
• Countries: France

The European Medicine Industry Brief

• Industry report
• May 2012
• 5 pages

• Industries: Drug and Medication
• Countries: Europe, United Kingdom, France

Drug and Medication Market in The United States, France and Spain

• Industry report
• November 2011
• 36 pages

... By advancing patient discharge dates from hospitals and eliminating additional tests, such as mris, x-rays, cat scans and nuclear medicine examinations that are used to reaffirm a medical diagnosis. 4 I.1 ...

• Industries: Drug and Medication
• Countries: United States, France, Spain

Drug and Medication Sector in France

• Industry report
• November 2011
• 10 pages

... Was also inhibited by 10 mm mehp, whereas 17 alpha-hydroxyprogesterone (17a-ohp) production was found to increase (+41%). testosterone synthesis was rescued by the addition of androstenedione but not by any ...

• Industries: Drug and Medication
• Countries: France

Medicine Sector in Europe

• Industry report
• December 2011
• 20 pages

... Part i Drug packaging and children: prescrire S overview of the situation as of 2011 far too often, the packaging of paediatric medicines creates a risk of medication errors and far too many ...

• Industries: Drug and Medication
• Countries: Europe, France

World Drug and Medication Industry

• Industry report
• March 2013
• 40 pages

... hydroquinone Highly toxic to skin and linked to cancer Unstable Banned in several countries Major adverse events monobenzyl ether of hydroquinone or monobenzone (mbeh) Nearly irreversible ...

• Industries: Drug and Medication
• Countries: France, World, Europe